WongPartnership LLP

Business Establishment; Corporate Governance & Compliance; Employment; Health Sciences & Biotechnology; Mergers & Acquisitions; Philippines; Professional Services

Vivien Yui is the Co-Head of the Employment Practice and is a Partner in the Mergers & Acquisitions, Business Establishment, Corporate Governance & Compliance, Health Sciences & Biotechnology, Professional Services and Philippines Practices.

Her main practice areas are private mergers and acquisitions, employment, corporate governance and compliance and general corporate and commercial work.

Vivien practises general corporate law, with an emphasis on representing private equity investments, especially in biotechnology and biomedical companies. As the Joint Head of the Firm's Employment Practice, she regularly advises multinational corporations on their global share incentive plans and establishment of local employment practices, benefits and policies. She also assists clients with immigration law and regulatory issues.

Vivien has been praised in The Legal 500 as "very practical", "knowledgeable" and "responsive to clients' needs". In asialaw Profiles a client provided feedback that ʺVivien's bedside manner is unparalleled. Her commercial acumen from years in capital markets work also uniquely places her amongst the top regulatory and compliance lawyersʺ. The client also noted that ʺShe is our conscience at times, which tells you how much trust we have in her judgement and adviceʺ.

Apart from her practice, Vivien is also an adjunct instructor with the School of Law at the Singapore Management University and teaches at The National University of Singapore Faculty of Law as a guest lecturer.

Vivien graduated from the National University of Singapore and is admitted to the Singapore Bar.

Relevant experience:

Significant transactions that Vivien has been involved in include advising / acting for the following:

GlaxoSmithKline plc ("GSK"), as Singapore counsel, on corporate/commercial and employment matters in relation to GSK's three-part transaction with Novartis International AG ("Novartis") pursuant to which GSK acquired Novartis's global vaccines business (excluding influenza vaccines) for an initial cash consideration of US$5.25 billion. The deal was one of the winning deals in Asian-mena Counsel Deals of the Year, 2015. ESR Funds Management (S) Limited (the manager of ESR-REIT), in the merger with Viva Industrial Trust by way of a trust scheme of arrangement. The merger values Viva Industrial Trust at S$936.7 million and creates Singapore's fourth largest industrial REIT with approximately S$3 billion in property assets. This deal won ʺBest Singapore Dealʺ at the FinanceAsia Awards 2018 and ʺM&A Deal of the Year (Midsize)ʺ at the ALB SE Asia Law Awards, 2019. Clearbridge Health Limited ("CBH") in the acquisition of 49% of the issued and paid-up share capital of PT Tirta Medika Jaya ("TMJ") by Clearbridge Medical Asia Pte. Ltd., an indirect wholly-owned subsidiary of CBH, from Ark Investments (SG) Pte. Ltd. In connection with the Acquisition, CBMA also subscribed for an exchangeable bond issued by PT Genesis Kapital Investama, one of the shareholders of TMJ. Clearbridge BioMedics Pte. Ltd. in its S$6.6 million pre-IPO financing and the consolidation of its capital structure by converting all preferred shares and convertible securities to ordinary shares of Clearbridge BioMedics in preparation for the potential IPO. EFG BANK AG, Singapore Branch in the acquisition of BSI Bank Limited's Singapore private banking business. This follows the announcement on 22 February 2016 by EFG International and BSI Bank that EFG International will acquire BSI Bank to form one of the largest private banks in Switzerland with approximately CHF 170 billion in assets under management, for a purchase price of approximately CHF 1,328 million. Skyworks Solutions, Inc., in the labour and work visa matters in relation to its joint venture with Panasonic Corporation to design, develop and deliver high performance filters, including surface acoustic wave ("SAW") devices and temperature compensated SAW devices ("TC-SAW") and the acquisition by the joint venture of Panasonic Corporation's SAW and TC-SAW business in Singapore.

Publications:

The Legal 500: Country Comparative Guides – Singapore – Employee Incentives, 2024 Thomson Reuters Practical Law: Employee Share Plans Global Guide 2024 - Singapore Chapter Thomson Reuters Practical Law: Incorporating a Private Company Limited by Shares - Singapore Chapter Thomson Reuters Practical Law: Closing Down a Solvent Private Company - Singapore Chapter LegisWatch: New Tripartite Guidelines on Flexible Work Arrangement Requests Effective December 2024 LegisWatch: SGX RegCo Requires Large Issuers to Take Lead to Reduce AGM Crunch, Reserve AGM Slots in Advance LegisWatch: Changes to Mandatory Training Requirement for First-time Directors of SGX-listed Issuers LegisWatch: Changes to Conduct of Meetings: Companies, Business Trusts and Other Bodies (Miscellaneous Amendments) Act 2023 and Listing Manual Practice Notes on General Meetings LegisWatch: Changes to the Global Investor Programme LegisWatch: Changes to Listing Rules: Tenure of Independent Directors Capped at Nine Years; Remuneration of Directors and CEOs Must Be Disclosed LegisWatch: Enhanced Tripartite Guidelines on Exercising Sensitivity for Harmonious Workplace LegisWatch: Launch of Manpower for Strategic Economic Priorities Scheme

English, Mandarin